88 related articles for article (PubMed ID: 18708435)
1. Rituximab in Graves' disease.
Rodien P
Eur J Endocrinol; 2008 Nov; 159(5):515-6. PubMed ID: 18708435
[No Abstract] [Full Text] [Related]
2. Rituximab in relapsing Graves' disease, a phase II study.
Heemstra KA; Toes RE; Sepers J; Pereira AM; Corssmit EP; Huizinga TW; Romijn JA; Smit JW
Eur J Endocrinol; 2008 Nov; 159(5):609-15. PubMed ID: 18628345
[TBL] [Abstract][Full Text] [Related]
3. B-cell depletion with rituximab-a targeted therapy for Graves' disease and autoimmune thyroiditis.
Hasselbalch HC
Immunol Lett; 2003 Jul; 88(1):85-6. PubMed ID: 12853167
[No Abstract] [Full Text] [Related]
4. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease.
El Fassi D; Nielsen CH; Kjeldsen J; Clemmensen O; Hegedüs L
Gut; 2008 May; 57(5):714-5. PubMed ID: 18408106
[No Abstract] [Full Text] [Related]
5. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723
[TBL] [Abstract][Full Text] [Related]
6. Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease.
El Fassi D; Clemmensen O; Nielsen CH; Silkiss RZ; Hegedüs L
J Clin Endocrinol Metab; 2007 Oct; 92(10):3762-3. PubMed ID: 17933978
[No Abstract] [Full Text] [Related]
7. Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.
van Lieshout AW; Creemers MC; Radstake TR; Elving LD; van Riel PL
J Rheumatol; 2008 May; 35(5):938-9. PubMed ID: 18464319
[No Abstract] [Full Text] [Related]
8. [Rituximab: a new therapeutic alternative in Grave's disease].
Tello-Winniczuk N; Díaz-Jouanen E
Rev Invest Clin; 2011; 63(5):536-43. PubMed ID: 22468483
[TBL] [Abstract][Full Text] [Related]
9. Rituximab as a treatment alternative in sarcoidosis.
Belkhou A; Younsi R; El Bouchti I; El Hassani S
Joint Bone Spine; 2008 Jul; 75(4):511-2. PubMed ID: 18562234
[No Abstract] [Full Text] [Related]
10. Rituximab in rheumatic diseases.
Saraux A; Devauchelle V; Jousse S; Youinou P
Joint Bone Spine; 2007 Jan; 74(1):4-6. PubMed ID: 17178461
[No Abstract] [Full Text] [Related]
11. B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study.
El Fassi D; Nielsen CH; Bonnema SJ; Hasselbalch HC; Hegedüs L
J Clin Endocrinol Metab; 2007 May; 92(5):1769-72. PubMed ID: 17284622
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of rituximab in Felty's syndrome.
Shipley E; Héraud A; Hennette A; Vernhes JP
Joint Bone Spine; 2008 Oct; 75(5):621-2. PubMed ID: 18805034
[No Abstract] [Full Text] [Related]
13. Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis.
Baek WS; Bashey A; Sheean GL
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):771. PubMed ID: 17575026
[No Abstract] [Full Text] [Related]
14. Rituximab and abatacept for rheumatoid arthritis.
BMJ Group
Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
[TBL] [Abstract][Full Text] [Related]
15. [Rituximab for treatment of graves orbitopathy].
Huerva V
Arch Soc Esp Oftalmol; 2011 May; 86(5):162-3. PubMed ID: 21624658
[No Abstract] [Full Text] [Related]
16. Early onset neutropenia after rituximab in lupus nephritis.
Enríquez R; Borrás-Blasco J; Sirvent AE; Masía M; Amorós F
Clin Exp Rheumatol; 2007; 25(2):345. PubMed ID: 17543172
[No Abstract] [Full Text] [Related]
17. Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry.
Nocturne G; Dougados M; Constantin A; Richez C; Sellam J; Simon A; Wendling D; Mariette X; Gottenberg JE
Ann Rheum Dis; 2010 Feb; 69(2):471-2. PubMed ID: 20107035
[No Abstract] [Full Text] [Related]
18. Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab.
Gelinck LB; Teng YK; Rimmelzwaan GF; van den Bemt BJ; Kroon FP; van Laar JM
Ann Rheum Dis; 2007 Oct; 66(10):1402-3. PubMed ID: 17881666
[No Abstract] [Full Text] [Related]
19. [Novel treatment of Graves' disease using the B-lymphocyte depleting agent rituximab].
Nielsen CH; El Fassi D; Hegedüs L
Ugeskr Laeger; 2008 Jun; 170(24):2131-4. PubMed ID: 18565295
[TBL] [Abstract][Full Text] [Related]
20. [Do biologicals have a place in the treatment of collagen diseases? Pro].
Lorenz HM
Dtsch Med Wochenschr; 2009 Sep; 134(36):1764. PubMed ID: 19718598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
